Netherlands· NL-f9c9dd1c4390
Envarsus 0,75 mg, tablet met verlengde afgifte
A tacrolimus product containing tacrolimus 1-water, registered in Netherlands by Chiesi Farmaceutici S.P.A. The same ATC class is registered in 16 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Tacrolimus is registered in 16 of 19 countries.
Countries holding a registration under ATC L04AD02 (tacrolimus), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Tacrolimus · ATC L04AD02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tacrolimus costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.77 in United States to $15.16 in Switzerland — a ×20 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Tacrolimus · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$15.16
- IT Italy$8.99
- ES Spain$6.82
- US United States$0.77 (acquisition cost)
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- TACROLIMUS 1-WATER
- Manufacturer
- Chiesi Farmaceutici S.P.A
- Country
- Netherlands (NL)
- ATC code
- L04AD02
- ATC class
- Tacrolimus
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/14/935
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1075 interactions on record for tacrolimus.
Graded by severity as the source publishes them — 238 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tacrolimus · interactions on record
1075 records
- 238 severe
- 543 moderate
- 18 minor
- 217 info
Most severe, free to view
- ClotrimazoleA01AB18severe
- OmeprazoleA02BC01severe
- LansoprazoleA02BC03severe
- EsomeprazoleA02BC05severe
59 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tacrolimus in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaENVARSUSChiesi Farmaceutici S.p.A., Parma
- CanadaENVARSUS PAENDO OPERATIONS LTD.
- SpainEnvarsus 0,75mg comprimidos de liberacion prolongadaChiesi Farmaceutici S.P.A.
- FinlandEnvarsusChiesi Farmaceutici S.p.A.
- FranceENVARSUS 0,75 mg, comprimé à libération prolongéeCHIESI FARMACEUTICI
- United KingdomEnvarsus 750microgram modified-release tabletsChiesi Ltd
- IrelandEnvarsus 0.75 mg prolonged-release tabletsChiesi Farmaceutici S.p.A.
- IcelandEnvarsusChiesi Farmaceutici S.p.A.*
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Adport, Dailiport
- Belgium · Adoport, Dailiport
- Bulgaria · Програф
- Cyprus · Prograf, Tacrolimus Accord
- Czechia · Dailiport, Gecrol
- Germany · Crilomus, Dailiport
- Denmark · Adport, Dailiport
- Estonia · Dailiport, Lebsanan
- Spain · Adoport, Cellmune
- Finland · Adport, Adport,
- France · Adoport, Conferoport
- United Kingdom (Northern Ireland) · Adoport, Ascezo
- Greece · Atodrit-Dermo, Eczatope Derm
- Croatia · Atezyrix, Dermitopic
- Hungary · Prograf, Tacrolimus Stada
- Ireland · Prograf, Tacrolimus Accord
- Iceland · Advagraf, Dailiport
- Italy · Adoport, Carelimus
- Liechtenstein · Advagraf, Envarsus
- Lithuania · Dailiport, Lebsanan
- Luxembourg · Prograft, Sumilor
- Latvia · Dailiport, Lebsanan
- Malta · Prograf
- Norway · Adport, Advagraf
- Poland · Cidimus, Dailiport
- Portugal · Adoport, Dermitopic
- Romania · Prograf, Tacrolimus Sandoz
- Sweden · Adport, Adport,
- Slovenia · Adoport, Dailiport
- Slovakia · Atezyrix, Dailiport
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b246adb1-d377-4352-bba1-66074ad6a4d4 GET /v1/drugs/b246adb1-d377-4352-bba1-66074ad6a4d4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet met verlengde afgifte",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/envarsus-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Tacrolimus",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp113809",
"excipients": [
"BUTYLHYDROXYTOLUEEN (E 321)",
"DIMETICON (E 900)",
"HYPROMELLOSE (Release controlling polymer)(E 464)",
"LACTOSE 1-WATER",
"MACROGOL 6000",
"MAGNESIUMSTEARAAT (E 470b)",
"POLOXAMEER 188",
"WIJNSTEENZUUR, (L (+) Vorm) (E 334)"
],
"substances": [
"TACROLIMUS 1-WATER"
],
"leaflet_url": null,
"authorised_at": "2014/07/18",
"procedure_number": "EMEA/H/C/002655",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/14/935",
"additional_monitoring": "N"
}See everything about tacrolimus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.